Quanterix Corporation (QTRX): Price and Financial Metrics

Quanterix Corporation (QTRX): $12.83

0.58 (-4.33%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

QTRX Price/Volume Stats

Current price $12.83 52-week high $29.70
Prev. close $13.41 52-week low $12.81
Day low $12.81 Volume 570,300
Day high $13.69 Avg. volume 389,257
50-day MA $16.30 Dividend yield N/A
200-day MA $22.24 Market Cap 491.00M

QTRX Stock Price Chart Interactive Chart >


Quanterix Corporation (QTRX) Company Bio


Quanterix Corporation develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test. The company’s products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, assay development, and custom development services. Quanterix Corporation primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was founded in 2007 and is based in Lexington, Massachusetts.


QTRX Latest News Stream


Event/Time News Detail
Loading, please wait...

QTRX Latest Social Stream


Loading social stream, please wait...

View Full QTRX Social Stream

Latest QTRX News From Around the Web

Below are the latest news stories about QUANTERIX CORP that investors may wish to consider to help them evaluate QTRX as an investment opportunity.

Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference

BILLERICA, Mass., December 12, 2023--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will present at the 42nd Annual J.P. Morgan Healthcare Conference. Quanterix’s session will take place on Wednesday, January 10, 2024, at 5:15 p.m., PST.

Yahoo | December 12, 2023

Here's Why Quanterix Corporation (QTRX) is a Great Momentum Stock to Buy

Does Quanterix Corporation (QTRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Yahoo | December 4, 2023

Does Quanterix Corporation (QTRX) Have the Potential to Rally 33.74% as Wall Street Analysts Expect?

The mean of analysts' price targets for Quanterix Corporation (QTRX) points to a 33.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | November 29, 2023

Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

BILLERICA, Mass., November 13, 2023--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will speak in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16, 2023 at 3:00 PM ET. To access the live webcast, please register here. A replay will be available following the conference on Quante

Yahoo | November 13, 2023

Wall Street Analysts See a 54.88% Upside in Quanterix Corporation (QTRX): Can the Stock Really Move This High?

The mean of analysts' price targets for Quanterix Corporation (QTRX) points to a 54.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | November 13, 2023

Read More 'QTRX' Stories Here

QTRX Price Returns

1-mo -22.52%
3-mo -45.01%
6-mo N/A
1-year -42.80%
3-year -79.80%
5-year -62.06%
YTD -53.07%
2023 97.40%
2022 -67.33%
2021 -8.82%
2020 96.78%
2019 29.06%

Continue Researching QTRX

Want to see what other sources are saying about Quanterix Corp's financials and stock price? Try the links below:

Quanterix Corp (QTRX) Stock Price | Nasdaq
Quanterix Corp (QTRX) Stock Quote, History and News - Yahoo Finance
Quanterix Corp (QTRX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!